UiPath Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? UiPath Inc trades at $13.26 (market cap $6.81B), while iShares Broad USD Investment Grade Corporate Bond trades at $48.71 (market cap $17.48B). The key difference: iShares Broad USD Investment Grade Corporate Bond is far larger — about 2.6× UiPath Inc's market cap, and UiPath Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold UiPath Inc for 139 Days and iShares Broad USD Investment Grade Corporate Bond for 44 Days on average.
| PATH | USIG | |
|---|---|---|
Market Cap | $6.81B | $17.48B |
Volume | 22,766,109 | 2,226,889 |
Sector | Technology | Fixed Income |
52-Week High | $19.29 | $52.69 |
52-Week Low | $9.38 | $48.54 |
Typical Hold Time | 139 Days | 44 Days |
Enterprise Value | $5.61B | — |
Signals from Pluang's Aura AI — not financial advice
UiPath (PATH) trades at $13.25, up 1.15% with mixed technical signals showing bearish momentum but neutral oscillators. The company demonstrates improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while transitioning from net losses to profitability. Recent partnerships with Snowflake and BDO highlight strategic positioning in AI automation, though the stock faces near-term headwinds from valuation concerns and competitive pressures.
PATH presents a turnaround story with strong revenue growth and path to profitability, but faces execution risks amid competitive automation landscape. The consensus price target of $15.13 suggests 14% upside potential, though technical weakness and mixed analyst sentiment warrant caution. Key catalysts include AI platform adoption and enterprise expansion, while risks involve growth sustainability and margin pressures.
USIG trades at $48.68 with minimal daily movement (+0.06%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators are neutral. The stock faces resistance at $49 and support at $48. Recent institutional activity includes Blue Edge Capital's new $21.9 million position and Bank of New York Mellon increasing its stake by 0.9%.
The outlook remains cautious due to bearish technical signals and lack of fundamental data. Investment opportunities include potential support at $48 and institutional accumulation. Key risks involve market volatility and absence of current financial metrics. Investors should await updated earnings reports for fundamental clarity.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →